Hospitals, Strapped for Cash, Are Buying Surgical Robots Despite Pandemic Volatility

article image

Despite COVID-19 challenges to healthcare system finances and a lack of clinical evidence for some of the most common robotic procedures, surgical robotics remains one of the best growth opportunities in the medical device industry.

The market for surgical robotics is one of the largest and fastest growing in the medical device sector, with expansive opportunity ahead as only 2% of global surgical procedures currently involve robotic assistance. Robust demand has continued despite the pandemic’s dampening impact on elective procedures and hospital finances. (See “Robotics Uptake: Cutting Through the COVID-19 Noise,” MedTech Strategist, December 16, 2020.)


This article is restricted to subscribers only.

To continue reading, select one of the options below:

Existing Subscriber?

Sign In to continue reading.

Need Multi-User Access?

Gain access for your entire organization.

Get Quote Check to see if your company already has access

Subscribe to MedTech Strategist:

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe to MedTech Strategist
Sign up for All-Access

Join our global community with a subscription to both MedTech Strategist and Market Pathways for one low price.



We're here to help! Please contact us at: